Mydecine Innovations Group Inc. announced the appointment of Dr. Victoria Hale to the company's Board of Directors. Dr. Hale is a pharmaceutical scientist and executive, as well as a global health social entrepreneur. She currently serves as Chair of the Board of the Multidisciplinary Association for Psychedelic Studies (MAPS).
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.011 USD | +47.33% | +46.05% | -25.50% |
01/05 | Mydecine Innovations Group Inc. announced that it expects to receive CAD 1 million in funding | CI |
23/02 | Mydecine Innovations Closes Partial Debt Settlement | MT |
1st Jan change | Capi. | |
---|---|---|
-25.50% | 5L | |
+49.20% | 5.69TCr | |
+39.98% | 4.03TCr | |
-7.05% | 3.93TCr | |
-4.42% | 2.84TCr | |
+12.39% | 2.64TCr | |
-17.92% | 1.94TCr | |
+29.48% | 1.25TCr | |
+25.68% | 1.22TCr | |
-0.22% | 1.21TCr |
- Stock Market
- Equities
- MYCOF Stock
- News Mydecine Innovations Group Inc.
- Mydecine Innovations Group Inc. Appoints Victoria Hale as Newest Independent Board Member